MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub to Improve Access to GLP-1 and Critical Care Medicines

Oct 28, 2025

Bengaluru (Karnataka) [India], October 28: MrMed, India's largest online super-specialty pharmacy, has opened a state-of-the-art cold-chain distribution hub in Bengaluru. The new facility strengthens...

Generic Semaglutide patent expiry opens over Rs 50,000 Crore opportunity for drugmakers: Report

Jan 03, 2026

In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth...

Govt issues guidelines on GLP-1 Drugs' use, risks, and regualtions

Apr 01, 2026

The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release.

Mayim Bialik reveals severe side effects after single GLP-1 dose

Jun 06, 2026

According to PEOPLE magazine, in an essay published in a U.S.-based digital news outlet, Bialik shared why she decided to try the medication and...

GLP-1 should not be used as a quick fix for weight loss and diabetes management, warns top experts

Mar 30, 2026

Top medical experts are raising urgent alarms against using GLP-1 as a lifestyle enhancer, highlighting the risk of shortages for high-risk patients.

Drug regulator inspects 49 entities over unauthorised sale of weight loss drugs

Mar 24, 2026

India's drug regulator has intensified monitoring of the supply chain of GLP-1-based weight loss drugs amid concerns over their unauthorised sale and misuse.